LeMaitre Vascular reported that it outperformed the industry growth forecast.
2 reports, 2 independent
Updated Aug 9
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
LeMaitre Vascular reported that it outperformed the industry growth forecast.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
LeMaitre Vascular (United States)
company in Burlington, United States
Coverage
Newest first; wire copies grouped- Simply Wall St.LeMaitre Vascular Second Quarter 2025 Earnings: Beats Expectations Revenue: US$64.2m (up 15% from 2Q 2024). Net income: US$13.8m (up 17% from 2Q 2024). Profit margin: 22% (in line with 2Q 2024). EPS:
- ZacksLeMaitre Vascular (LMAT) Beats Q2 Earnings and Revenue Estimates LeMaitre Vascular (LMAT) came out with quarterly earnings of $0.6 per share, beating the Zacks Consensus Estimate of $0.57 per share.